Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acotec Scientific HoldingsHKSE:06669 -0.47%76 Days Payable is 111.12 as of Dec. 2025, which is 36% above its 10-year median of 81.75. GuruFocus rates HKSE:06669 with a GF Score™ of 76/100 and a GF Value™ of HK$14.83 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Acotec Scientific Holdings ranks better than 70.35% on this metric.
The historical rank and industry rank for Acotec Scientific Holdings's Days Payable or its related term are showing as below:
HKSE:06669'
s Days Payable Range Over the Past 10 Years
Min: 3.91 Med: 81.75 Max: 115.62
Current: 115.62
During the past 7 years, Acotec Scientific Holdings's highest Days Payable was 115.62. The lowest was 3.91. And the median was 81.75.
HKSE:06669's Days Payable is ranked better than 70.35% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.68
vs HKSE:06669: 115.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06669 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Acotec Scientific Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's Days Payable falls into.
Acotec Scientific Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acotec Scientific Holdings (HKSE:06669) has a Days Payable of 111.12 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Acotec Scientific Holdings and its competitors. This is 36% above median its historical median of 81.75. Over the past decade, Acotec Scientific Holdings' Days Payable has ranged from 3.91 to 115.62. According to the industry distribution chart, Acotec Scientific Holdings ranks #236 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 29.6%.
Is Acotec Scientific Holdings' Days Payable too high?
Acotec Scientific Holdings' current Days Payable of 111.12 is 36% above median its 10-year median of 81.75. Over the past 10 years, this metric has ranged from a low of 3.91 to a high of 115.62. The Medical Devices & Instruments industry median Days Payable is 68.68. Acotec Scientific Holdings' value of 111.12 is 61.8% above this industry median. Based on the distribution chart, Acotec Scientific Holdings ranks #236 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Acotec Scientific Holdings ranks #236 out of 796 companies for Days Payable. This puts Acotec Scientific Holdings in the upper half of its industry. The industry median Days Payable is 68.68. Acotec Scientific Holdings' value of 111.12 is 61.8% above this benchmark. Historically, Acotec Scientific Holdings' own Days Payable has ranged from 3.91 to 115.62 over the past decade. While the company's 10-year median is 81.75 vs. the industry median of 68.68, Acotec Scientific Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.68, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acotec Scientific Holdings's current Days Payable of 111.12 is 61.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Acotec Scientific Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acotec Scientific Holdings's current Days Payable is 111.12, which is 36% above median its own 10-year median of 81.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.83, compared to a current price of HK$6.37 — trading 57.1% below its estimated fair value. The current Days Payable is 111.12, which is 36% above median its 10-year median of 81.75 and 61.8% above the Medical Devices & Instruments industry median of 68.68. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current Days Payable is 111.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?
Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued.
The current stock price of HK$6.37 is trading 57.1% below its estimated GF Value™ of HK$14.83.
GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:06669:
Days Payable: 111.12 (36% above median its 10-year median of 81.75)
GF Value™: HK$14.83 vs. price of HK$6.37 (57.1% below fair value)
Industry Position: 61.8% above the Medical Devices & Instruments median (#236 of 796)
No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score
Get the complete analysis for HKSE:06669
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06669 has been successfully added to your 
